S 05985 combination versus angiotensin II receptor blocker/calcium channel blocker: a comparison of blood pressure lowering - efficacy and safety

INTERVENTION: One oral or two capsules per day of: 1. S 05985 combination over a maximum duration of 14 months or 2. Angiotensin II receptor blocker/calcium channel blocker over a maximum duration of 6 months CONDITION: Essential arterial hypertension ; Circulatory System ; Arterial hypertension PRIMARY OUTCOME: 1. Efficacy of S 05985 combination versus comparator in blood pressure lowering ; 2. Safety assessment of treatments SECONDARY OUTCOME: 1. Efficacy of both combination strategies on ABPM parameters; 2. Long‐term safety assessment of S 05985 combination (14 months) INCLUSION CRITERIA: 1. Outpatients 2. Men or women 3. Aged 18 years old at least 4. Mild to moderate hypertensive patient